Sign Up to like & get
recommendations!
0
Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2018.01524
Abstract: Objective: Apolipoprotein A1 (ApoA1) is remarkably decreased in serum and ovarian tissues of ovarian cancer patients. ApoA1 and ApoA1 mimetic peptides can sequestrate pro-inflammatory phospholipids, some of which are known to activate a variety of…
read more here.
Keywords:
mimetic peptides;
anti tumorigenic;
ovarian cancer;
mimetic peptide ... See more keywords